NCT01889953

Brief Summary

This research is being done to study the safety and feasibility of recruiting patients eligible for EUS-guided biliary drainage (EGBD). Our goal is to prospectively study safety and effectiveness of this procedure.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2012

Typical duration for not_applicable

Geographic Reach
5 countries

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

December 4, 2012

Completed
7 months until next milestone

First Posted

Study publicly available on registry

July 1, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

May 25, 2015

Status Verified

January 1, 2015

Enrollment Period

2 years

First QC Date

December 4, 2012

Last Update Submit

May 22, 2015

Conditions

Keywords

EUS-Guided Biliary DrainageEndoscopic retrograde cholangiopancreatographyMalignant Biliary Obstruction

Outcome Measures

Primary Outcomes (1)

  • Effectiveness (Clinical success is defined as drop in bilirubin by 50%)

    Clinical success is defined as drop in bilirubin by 50% at 2 weeks and to below 3 (level

    From date of intervention up to 4 weeks

Secondary Outcomes (6)

  • Quality of life (QOL)

    From date of intervention up to 12 weeks

  • Procedure-related costs

    Lifetime (These patients have a life expectancy of less than 2 years)

  • Number of required procedures

    From date of intervention up to death (These patients have a life expectancy of less than 2 years)

  • Technical success

    Intra- and post intervention (These patients have a life expectancy of less than 2 years)

  • Stent patency

    Lifetime (These patients have a life expectancy of less than 2 years)

  • +1 more secondary outcomes

Study Arms (1)

EUS-guided biliary drainage

OTHER

Patients in this arm will receive EUS-guided biliary drainage.

Other: EUS-guided biliary drainage

Interventions

Based on the patient's condition, the will receive: * Rendezvous technique * Direct transluminal access transesophageal technique * Direct transluminal access transduodenal technique * or direct transluminal access using transgastric approach

EUS-guided biliary drainage

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive adult patients (18-80 years of age) with jaundice due to inoperable (by EUS and/or CT criteria or due to health status) malignant distal (more than 2cm distal to hilum) biliary obstruction and who have failed prior ERCP attempt. Failure is considered to be 2 unsuccessful attempts, according to each institution's definition of "failed" procedure (patients may be consented for EGBD prior to repeat ERCP due to higher likelihood of failure). One failure at outside institution and one failure at your institution can be considered as total of two failures.
  • Ability to give informed consent

You may not qualify if:

  • Unable to give informed consent
  • Life expectancy \< 1month
  • Pregnant or breastfeeding women
  • Acute gastrointestinal bleeding
  • Coagulopathy defined by prothrombin time \< 50% of control; PTT \> 50 sec, or INR \> 1.5), or on chronic anticoagulation
  • Inability to tolerate sedated upper endoscopy due to cardio-pulmonary instability or other contraindication to endoscopy.
  • Prior total gastrectomy, Roux-en-Y gastric bypass, esophagectomy and sleeve gastrectomy
  • ESLD with portal hypertension, varices, and/or ascites
  • Liver metastases burden \> 30%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

University of Colorado

Aurora, Colorado, 80045, United States

Location

University of Florida

Gainesville, Florida, 32607, United States

Location

Florida Hospital

Orlando, Florida, 32803, United States

Location

Indiana University

Bloomington, Indiana, 47405, United States

Location

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

Winthrop University Hospital

Mineola, New York, 11501, United States

Location

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

All India Institute of Medical Sciences

Delhi, 110029, India

Location

Institute of advanced endoscopy

Mumbai, 400036, India

Location

Ismett/Upmc

Palermo, 90100, Italy

Location

Aichi Cancer Center Hospital

Nagoya, Aichi-ken, 464-8681, Japan

Location

Academic Medical Center of Amsterdam

Amsterdam, 1105, Netherlands

Location

Erasmus Medical Center

Rotterdam, 3000, Netherlands

Location

Related Publications (1)

  • Khashab MA, Van der Merwe S, Kunda R, El Zein MH, Teoh AY, Marson FP, Fabbri C, Tarantino I, Varadarajulu S, Modayil RJ, Stavropoulos SN, Penas I, Ngamruengphong S, Kumbhari V, Romagnuolo J, Shah R, Kalloo AN, Perez-Miranda M, Artifon EL. Prospective international multicenter study on endoscopic ultrasound-guided biliary drainage for patients with malignant distal biliary obstruction after failed endoscopic retrograde cholangiopancreatography. Endosc Int Open. 2016 Apr;4(4):E487-96. doi: 10.1055/s-0042-102648. Epub 2016 Mar 30.

Study Officials

  • Mouen A Khashab, MD

    Johns Hopkins Hospital Department of Gastroenterology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine; Director of Therapeutic Endoscopy

Study Record Dates

First Submitted

December 4, 2012

First Posted

July 1, 2013

Study Start

December 1, 2012

Primary Completion

December 1, 2014

Study Completion

January 1, 2015

Last Updated

May 25, 2015

Record last verified: 2015-01

Locations